New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

Metformin, a common medication used to treat type 2 diabetes, may also help reduce the viral reservoir in people living with ...

Scientists at the Medical College of Georgia at Augusta University are searching for a new treatment target for a common ...

Combination may offer a substitute to basal-bolus insulin in people with type 2 diabetes inadequately controlled with daily basal insulin.

The U.S. healthcare system, built on binary disease definitions, is not prepared to handle the complexities of weight loss ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...

New research published in New England Journal of Medicine and presented at this year's Annual Meeting of the European ...

Obesity is a global health burden and is closely associated with severe chronic co-morbidities, which remain the leading causes of death. Significant progress has been made in the treatment of ...